Dr. Agarwal’s HealthCare IPO – Review
Dr. Agarwal’s Healthcare Limited – dedicated to advancing healthcare in India through innovation and expertise is planning to raise INR 3027.26 Crore via IPO.
[Fresh Issue 300 Crore + OFS 2727.26]
Dr agarwal healthcare ipo price is INR INR 382 – 402 per share
Dr. Agarwal Healthcare: History
The Company was incorporated as Dr. Agarwal’s Health Care Limited in (Chennai, Tamil Nadu) as a public limited company under the Companies Act, 1956.
Last Article – Denta Water And Infra IPO
Dr. Agarwal Healthcare: Business
Dr. Agarwal’s Healthcare provides a wide range of eye care services including –
- Cataract surgeries,
- Refractive and other surgeries;
- Consultations,
- Diagnoses, and
- Non-surgical treatments;
The Company’s business operations are structured as a “hub and spoke model”, which enables it to build a scalable and accessible platform for the continued growth of its business.
With a long-standing operating history, the company endeavor to address all the needs of patients in their eye treatment journey through a network comprised of 180 Facilities.
International Business
In addition to business operations in India, Dr. Agarwal Healthcare commenced international operations in the year 2012 and operates around 15 facilities across 9 countries in Africa, where the company provides a range of services including,
- Eye care services (treatments for cataracts, diabetic retinopathy, glaucoma, retinal detachment, and dry eye, along with refractive surgeries,
- Paediatric and Neuro ophthalmological treatments
Dr. Agarwal Healthcare: Products
- Sale Contact lenses, Opticals, and other Accessories: The Company offers a wide range of contact lenses and frames, glasses, and lenses, at its facilities; and
- Sale of Eye care-related Pharmaceutical products: The Company sells certain eye care-related pharmaceutical products as prescribed by its doctors.
Market Share
During FY 2024, the Company had a market share of around 25 percent of the total eye care service chain market in India (Source: CRISIL MI&A Report).
Geographical Reach
The company operated in 193 facilities across 117 metro cities and non-metro cities spanning 14 states, and 4 union territories (UT) in India (as of 30 September 2024)
Competitive Strengths
- Largest eye care services provider in the country with a trusted brand
- End-to-end, comprehensive eye care services offering
- Scalable, hub-and-spoke, Asset-Light business model
- Proven clinical excellence (driven by a strong clinical board and history of surgical innovations)
- Doctor-promoters team (qualified medical professionals and supported by experienced management)
- Good track record of delivering organic growth,
Strategies Ahead
- Continued organic expansion of the company’s network in India
- Strengthen the company’s brand with the community, doctors, and patients in India
- Undertake acquisitions and restructuring to scale the company’s operations, leveraging its experience of inorganic growth and integration
- Attracting and retaining qualified doctors and paramedics through continuous training, upskilling, and knowledge-sharing
- Focus on improving profitability and Facility-level growth
Company Promoters
- Dr. Amar Agarwal,
- Dr. Adil Agarwal,
- Dr. Anosh Agarwal,
IPO Details
Dr Agarwal Healthcare IPO date = 29 Jan to 31 Jan 2025
Minimum Amount = INR 14,070
Minimum Bid = 35 Shares
Face Value (FV) = INR 1
Listing On = NSE, BSE
Book Running Lead Managers
Kotak Mahindra Capital Co. Ltd,
Morgan Stanley India Co. Pvt Ltd,
Jefferies India Pvt Ltd,
Motilal Oswal Investment Advisors Ltd
FINANCIALS
CONCLUSION
FinBlab recommends ‘MAY SUBSCRIBE‘ ratings on Dr. Agarwal’s Healthcare ipo
Disclaimer: The contents and data presented here are just for your information & personal use only. While much effort is made to provide the information, I ( Vishal Dalwadi ) or “FinBlab” do not guarantee the accuracy, correctness, completeness or reliability of any information or data displayed herein and shall not be held responsible.
